These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24407057)

  • 41. Identification of metal allergens in the local lymph node assay.
    Basketter DA; Lea LJ; Cooper KJ; Ryan CA; Gerberick GF; Dearman RJ; Kimber I
    Am J Contact Dermat; 1999 Dec; 10(4):207-12. PubMed ID: 10594296
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development and utilization of an ex vivo bromodeoxyuridine local lymph node assay protocol for assessing potential chemical sensitizers.
    Williams WC; Copeland C; Boykin E; Quell SJ; Lehmann DM
    J Appl Toxicol; 2015 Jan; 35(1):29-40. PubMed ID: 24532485
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A new in vitro method for identifying chemical sensitizers combining peptide binding with ARE/EpRE-mediated gene expression in human skin cells.
    McKim JM; Keller DJ; Gorski JR
    Cutan Ocul Toxicol; 2010 Sep; 29(3):171-92. PubMed ID: 20491607
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acceptable surface limits (ASLs) of skin sensitizers derived from the local lymph node assay (LLNA): BrdU-ELISA EC1.6 values and their relationships to known sensitization potency information.
    Fukushima A; Hayashi T; Takeyoshi M
    J Appl Toxicol; 2022 Oct; 42(10):1723-1730. PubMed ID: 35580980
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative sensitizing potencies of fragrances, preservatives, and hair dyes.
    Lidén C; Yazar K; Johansen JD; Karlberg AT; Uter W; White IR
    Contact Dermatitis; 2016 Nov; 75(5):265-275. PubMed ID: 27633650
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The GARD platform for potency assessment of skin sensitizing chemicals.
    Zeller KS; Forreryd A; Lindberg T; Gradin R; Chawade A; Lindstedt M
    ALTEX; 2017; 34(4):539-559. PubMed ID: 29156079
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Principles for identification of High Potency Category Chemicals for which the Dermal Sensitisation Threshold (DST) approach should not be applied.
    Roberts DW; Api AM; Safford RJ; Lalko JF
    Regul Toxicol Pharmacol; 2015 Aug; 72(3):683-93. PubMed ID: 25765509
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relating skin sensitizing potency to chemical reactivity: reactive Michael acceptors inhibit NF-κB signaling and are less sensitizing than S(N)Ar- and S(N)2- reactive chemicals.
    Natsch A; Haupt T; Laue H
    Chem Res Toxicol; 2011 Nov; 24(11):2018-27. PubMed ID: 22023385
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nothing is perfect, not even the local lymph node assay: a commentary and the implications for REACH.
    Basketter DA; McFadden JF; Gerberick F; Cockshott A; Kimber I
    Contact Dermatitis; 2009 Feb; 60(2):65-9. PubMed ID: 19207375
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prediction of skin sensitization potency of chemicals by human Cell Line Activation Test (h-CLAT) and an attempt at classifying skin sensitization potency.
    Nukada Y; Ashikaga T; Miyazawa M; Hirota M; Sakaguchi H; Sasa H; Nishiyama N
    Toxicol In Vitro; 2012 Oct; 26(7):1150-60. PubMed ID: 22796097
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Computer models versus reality: how well do in silico models currently predict the sensitization potential of a substance.
    Teubner W; Mehling A; Schuster PX; Guth K; Worth A; Burton J; van Ravenzwaay B; Landsiedel R
    Regul Toxicol Pharmacol; 2013 Dec; 67(3):468-85. PubMed ID: 24090701
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Categorization of fragrance contact allergens for prioritization of preventive measures: clinical and experimental data and consideration of structure-activity relationships.
    Uter W; Johansen JD; Börje A; Karlberg AT; Lidén C; Rastogi S; Roberts D; White IR
    Contact Dermatitis; 2013 Oct; 69(4):196-230. PubMed ID: 23889298
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of radioisotopic and non-radioisotopic versions of local lymph node assays for subcategorization of skin sensitizers compliant to UN GHS rev 4.
    Ha S; Ahn IY; Kim DE; Lee JK; Sohn S; Jung MS; Heo Y; Omori T; Bae S; Lim KM
    Regul Toxicol Pharmacol; 2017 Apr; 85():124-131. PubMed ID: 28193562
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extrapolating local lymph node assay EC3 values to estimate relative sensitizing potency.
    Ryan CA; Chaney JG; Gerberick GF; Kern PS; Dearman RJ; Kimber I; Basketter DA
    Cutan Ocul Toxicol; 2007; 26(2):135-45. PubMed ID: 17612980
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Skin sensitization of epoxyaldehydes: importance of conjugation.
    Delaine T; Hagvall L; Rudbäck J; Luthman K; Karlberg AT
    Chem Res Toxicol; 2013 May; 26(5):674-84. PubMed ID: 23534857
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Allergic contact dermatitis caused by farnesol: clinical relevance.
    Gilpin S; Maibach H
    Cutan Ocul Toxicol; 2010 Dec; 29(4):278-87. PubMed ID: 20858058
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An epidermal equivalent assay for identification and ranking potency of contact sensitizers.
    Gibbs S; Corsini E; Spiekstra SW; Galbiati V; Fuchs HW; Degeorge G; Troese M; Hayden P; Deng W; Roggen E
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):529-41. PubMed ID: 23876969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proposal for a risk assessment methodology for skin sensitization based on sensitization potency data.
    Griem P; Goebel C; Scheffler H
    Regul Toxicol Pharmacol; 2003 Dec; 38(3):269-90. PubMed ID: 14623479
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Skin irritation and sensitization: mechanisms and new approaches for risk assessment.
    Basketter D; Darlenski R; Fluhr JW
    Skin Pharmacol Physiol; 2008; 21(4):191-202. PubMed ID: 18509253
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Skin sensitization: Implications for integration of clinical data into hazard identification and risk assessment.
    Basketter DA; White IR; McFadden JP; Kimber I
    Hum Exp Toxicol; 2015 Dec; 34(12):1222-30. PubMed ID: 26614809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.